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Introduction
Stereotactic body radiotherapy (SBRT) with photons to
treat extra-cranial tumors in a single fraction has been
shown to yield local control rates > 80 % with acceptable
toxicity [1]. Scanned particle therapy (PT) has proven its
efficacy for head and neck tumors, while treatment of mo-
bile tumors of the lung is still challenging due to interplay
and range changes. We performed an in silico case study
comparing SBRT and PT (carbon ions) in lung cancer pa-
tients to investigate potential benefits of PT in radiosurgery.
Materials and methods
We used data of nine patients that were actually treated
with SBRT at Fundac¸a˜o Champalimaud, Lisbon. The pre-
scribed target dose is at least 24 Gy for 99 % of the target
volume, with strict adherence to dose constraints for organs
at risk (OAR). The actual SBRT treatment plans are com-
pared to simulated treatment with PT using TRiP98 [2] on
a 4D-CT. For SBRT, isotropic ITV-PTV margins of 3 mm
were used. Due to range changes in PT we added margins
3 mm laterally and 1 mm in beam’s eye view on CTV and
then computed a range-considering ITV with 2 mm + 2 %
range margins. Five times slice-by-slice rescanning was
used to counter interplay.
Figure 1: Dose cuts for SBRT (left) and PT (right) in two
patients. The first patient (top) shows a favorable dose dis-
tribution of PT, while the second case (bottom) appears bet-
ter suited for SBRT.
Results
Average peak to peak tumor motion was 5.6 mm (from
0.2 mm to 9.5 mm). Comparison of dose cuts between
SBRT and PT is shown in Figure 1. Both therapies pro-
vided excellent target coverage and OAR doses within tol-
erances, except for three patients, where maximal allowed
point dose in smaller airways was exceeded due to tumor
proximity. Differences between SBRT and PT in dose de-
position for 7 specific OAR are shown in Figure 2. On
average all OAR receive less dose in PT, except for ipsi-
lateral lung D10%. The most profound difference was in
spinal cord and ipsilateral lung D10%, where the average
dose difference was 4.2 Gy and -4.5 Gy, respectively.
Discussion
The results clearly indicate potential of PT in treating
lung cancer. With smaller entry channel than SBRT, PT can
deposit less dose in OAR, while maintaining same target
coverage. This advantage varies with patient anatomy and
lesion location, motion and size. The clinical relevance of
possible further dose escalation or improved OAR sparing
with scanned carbon ion therapy needs to be validated. This
study will include a total of 20 patients, and also further
investigate the robustness of PT.
Figure 2: Box-and-whisker plot for dose difference be-
tween SBRT and PT for different OAR. Boxes contain data
between 25 % and 75 %, dashed lines represent mean value
and whiskers minimum and maximum values.
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